The Journal of Headache and Pain

Aims and scope

The Journal of Headache and Pain is a peer-reviewed open access journal specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data. With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine. Read more.

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Q&A with Authors

Click here to see Q&As with the authors of the journal's most highly viewed articles!

Featured article: Headache medication and the COVID-19 pandemic

Articles

A prospective real-world analysis of erenumab in refractory chronic migraine

Authors: Giorgio Lambru, Bethany Hill, Madeleine Murphy, Ivona Tylova and Anna P. Andreou

Content type: Research article

1 June 2020
The applicability of web-based solutions in headache epidemiology research

Authors: Kati Toom, Aire Raidvee and Mark Braschinsky

Content type: Research article

1 June 2020
Microstructural changes in the trigeminal nerve of patients with episodic migraine assessed using magnetic resonance imaging

Authors: Tiffani J. Mungoven, Noemi Meylakh, Kasia K. Marciszewski, Vaughan G. Macefield, Paul M. Macey and Luke A. Henderson

Content type: Research article

29 May 2020
The impact of remission and coexisting migraine on anxiety and depression in cluster headache

Authors: Byung-Su Kim, Pil-Wook Chung, Byung-Kun Kim, Mi Ji Lee, Jeong Wook Park, Min Kyung Chu, Jin-Young Ahn, Dae Woong Bae, Tae-Jin Song, Jong-Hee Sohn, Kyungmi Oh, Daeyoung Kim, Jae-Moon Kim, Soo-Kyoung Kim, Yun-Ju Choi, Jae Myun Chung…

Content type: Research article

29 May 2020
Volume of the rectus capitis posterior minor muscle in migraine patients: a cross-sectional structural MRI study

Authors: Jeppe Hvedstrup, Faisal Mohammad Amin, Anders Hougaard, Håkan Ashina, Casper Emil Christensen, Henrik Bo Wiberg Larsson, Messoud Ashina and Henrik Winther Schytz

Content type: Research article

27 May 2020

Most recent articles RSS

View all articles

Headache associated with cough: a review

Authors: Ann Cordenier, Willem De Hertogh, Jacques De Keyser and Jan Versijpt

Content type: Review article

20 May 2013
The red ear syndrome

Authors: Giorgio Lambru, Sarah Miller and Manjit S Matharu

Content type: Review article

4 October 2013
Blocking CGRP in migraine patients – a review of pros and cons

Authors: Marie Deen, Edvige Correnti, Katharina Kamm, Tim Kelderman, Laura Papetti, Eloisa Rubio-Beltrán, Simone Vigneri, Lars Edvinsson and Antoinette Maassen Van Den Brink

Content type: Review article

25 September 2017
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population

Authors: Delphine Magis, Simona Sava, Tullia Sasso d’Elia, Roberta Baschi and Jean Schoenen

Content type: Research article

1 December 2013
A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome

Authors: Yu-Chen Cheng, Kuei-Hong Kuo and Tzu-Hsien Lai

Content type: Research article

1 March 2014

Most accessed articles RSS

View all articles

_{Editorial | 21 February 2018}
Migraine is first cause of disability in under 50s: will health politicians now take notice?
_{Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen and Z. Katsarava}

_{Research | 05 February 2018}
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
_{Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, Amelia Orejudos and Aubrey Manack Adams}

_{Consensus article | 16 January 2019}
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
^{Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas and Paolo Martelletti}

_{Research | 01 February 2018}
Poor medical care for people with migraine in Europe – evidence from the Eurolight study
^{Zaza Katsarava, Maka Mania, Christian Lampl, Johanna Herberhold and Timothy J. Steiner}

_{Review | 12 March 2018}
The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
^{Karl Messlinger}

_{Review | 09 March 2018}
PACAP and its role in primary headaches
_{Lars Edvinsson, János Tajti, Levente Szalárdy and László Vécsei}

_{Review | 07 August 2018}
PACAP38 and PAC1 receptor blockade: a new target for headache?
_{Eloisa Rubio-Beltrán, Edvige Correnti, Marie Deen, Katharina Kamm, Tim Kelderman, Laura Papetti, Simone Vigneri, Antoinette MaassenVanDenBrink and Lars Edvinsson}

_{Research | 24 May 2018}
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
^{Eric P. Baron, Philippe Lucas, Joshua Eades and Olivia Hogue}

_{Consensus article | 08 October 2018}
European Headache Federation guideline on idiopathic intracranial hypertension
^{Jan Hoffmann, Susan P Mollan, Koen Paemeleire, Christian Lampl, Rigmor H Jensen and Alexandra J Sinclair}

_{Research | 18 January 2018}
Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry
^{Mads Barloese, Anja Petersen, Philipp Stude, Tim Jürgens, Rigmor Højland Jensen and Arne May}

_{Publication years: 2018-2019
Source: Web of Science, data collected: March 2020}

European Headache Federation School of Advanced Studies

The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.

The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.

Editorial Office

Editor in Chief (Founding)
Paolo Martelletti, MD,
Department of Clinical and Molecular Medicine
Sapienza University of Rome
Via di Grottarossa 1035
I-00189 Rome, Italy
Tel.: +39-06-33775111
Fax: +39-06-33775110
E-mail: paolo.martelletti@uniroma1.it

Assistant to the Editor: Valerio De Angelis
E-mail: valerio.deangelis@uniroma1.it

An Unexpected and Suspended Time

Click here for a message from the Editor-in-Chief regarding COVID-19.

Featured article: Emerging evidence of occipital nerve compression in unremitting head and neck pain

Article collections

Click here to see the article collections and thematic series that the journal has published in recent years.

In Review

The Journal of Headache and Pain has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.

Hot topics in headache and pain from the EHF-SAS

Edited by Prof Paolo Martelletti
Open to submissions

Editorial Board Spotlight

Prof. Lars Edvinsson is a Professor in Internal Medicine, University of Lund, Sweden, and in Clinical and Experimental receptor regulation at Copenhagen University. He has spent 35 years on finding CGRP, building the case of its importance in migraine and cluster headache, and finally seeing the fulfillment of its therapeutic usefulness. The monoclonal antibodies in prevention of chronic and frequent episodic migraine, and he has been instrumental in the early work on gepants, small molecules that block the CGRP receptor. These are now in late phase for implementation in both acute and prophylactic therapy of migraine. His current work focus on novel targets for treatment of primary headaches.

Latest blogs

It’s not just a headache! A patient’s perspective on the advances in migraine treatment over the last 25 years

05 September 2019
How do sex hormones influence migraine?

02 September 2019
The New Era Of Disease Modifying Migraine Drugs (DMMDs)

01 September 2019

Academic education in headache

The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.

For more information:

Master in Headache Medicine
Sapienza University
Academic Year 2019-2020

Master of Headache Disorders
University of Copenhagen
Academic Years 2018-2020